Clinical Trials Browser

Phase 2 × Interventional × Estrogen-receptor Positive Invasive Metastatic Breast Cancer × Clear all

NCT01594216 2024-06-12

Ruxolitinib in Estrogen Receptor Positive Breast Cancer

Phase 2 Completed

25 enrolled 8 charts

Estrogen-receptor Positive Invasive Metastatic Breast Cancer